Phase II HL-1186 low-dose group:After the first dose of 160mg HL-1186 tablets orally, HL-1186 mimics or 800mg HL-1186 tablets orally were given every 6h for a total of 8 times

To evaluate the efficacy and safety of HL-1186 tablets for abdominal postoperative analgesia in a multicenter, randomized, double-blind, placebo-positive parallel controlled phase ?/? clinical trial

To evaluate the efficacy and safety of HL-1186 tablets for orthopedic postoperative analgesia in a multicenter, randomized, double-blind, placebo-positive parallel controlled phase ?/? clinical trial